DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Lawitz E, Lalezari JP, Hassanein T et al.
Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial.
Lancet Infect Dis 2013;
13: 401-408
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.